Search Results - Steigelman, Mary

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Safety and efficacy of radioimmunotherapy (RIT) in treatment of non-Hodgkin's lymphoma in the community setting

    Safety and efficacy of radioimmunotherapy (RIT) in treatment of non-Hodgkin's lymphoma in the community setting by Hadid, Tarik, Raufi, Ali, Kafri, Zyad, Mandziara, Mary, Kalabat, John, Szpunar, Susan, Kolizeras, Kleanthe, Steigelman, Mary, Al-Katib, Ayad

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    The BCL2 Targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 Is Active in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma

    The BCL2 Targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 Is Active in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma by Harb, Wael A., Lakhani, Nehal, Logsdon, Ana, Steigelman, Mary, Smith-Green, Heidi, Gaylor, Shari, Rodrigueza, Wendi, Woolliscroft, Michael, Sooch, Mina, Messmann, Richard A., Al-Katib, Ayad

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Anti CD-20 Radioimmunotherapy (RIT) Can Be Safely and Effectively Delivered in a Community-Based Hospital

    Anti CD-20 Radioimmunotherapy (RIT) Can Be Safely and Effectively Delivered in a Community-Based Hospital by Al-Katib, Ayad, Mandziara, Mary, Szpunar, Susan, Kolizeras, Kleanthe, Steigelman, Mary, Kalabat, John, Kafri, Zyad

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The BCL2 Targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 Is Active In Patients With Relapsed Or Refractory Non-Hodgkin's Lymphoma

    The BCL2 Targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 Is Active In Patients With Relapsed Or Refractory Non-Hodgkin's Lymphoma by Harb, Wael A., Lakhani, Nehal, Logsdon, Ana, Coordinator, Clinical Research, Steigelman, Mary, Smith-Green, Heidi, Gaylor, Shari, Woolliscroft, Michael, Rodrigueza, Wendi, Sooch, Mina, Messmann, Richard A., Al-Katib, Ayad

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Estrogen-regulated STAT1 activation promotes TLR8 expression to facilitate signaling via microRNA-21 in systemic lupus erythematosus

    Estrogen-regulated STAT1 activation promotes TLR8 expression to facilitate signaling via microRNA-21 in systemic lupus erythematosus by Young, Nicholas A, Valiente, Giancarlo R, Hampton, Jeffrey M, Wu, Lai-Chu, Burd, Craig J, Willis, William L, Bruss, Michael, Steigelman, Holly, Gotsatsenko, Maya, Amici, Stephanie A, Severin, Mary, Claverie, Lucila Marino, Guerau-de-Arellano, Mireia, Lovett-Racke, Amy, Ardoin, Stacy, Jarjour, Wael N

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: